Jasper Ridge Partners’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Hold |
20,870
| – | – | 0.01% | 133 |
|
|
2025
Q1 | $116K | Hold |
20,870
| – | – | ﹤0.01% | 136 |
|
|
2024
Q4 | $168K | Hold |
20,870
| – | – | 0.01% | 132 |
|
|
2024
Q3 | $214K | Hold |
20,870
| – | – | 0.01% | 129 |
|
|
2024
Q2 | $148K | Hold |
20,870
| – | – | ﹤0.01% | 134 |
|
|
2024
Q1 | $287K | Hold |
20,870
| – | – | 0.01% | 120 |
|
|
2023
Q4 | $192K | Hold |
20,870
| – | – | 0.01% | 133 |
|
|
2023
Q3 | $126K | Hold |
20,870
| – | – | 0.01% | 130 |
|
|
2023
Q2 | $162K | Hold |
20,870
| – | – | 0.01% | 129 |
|
|
2023
Q1 | $119K | Hold |
20,870
| – | – | 0.01% | 141 |
|
|
2022
Q4 | $123K | Hold |
20,870
| – | – | 0.01% | 138 |
|
|
2022
Q3 | $67K | Hold |
20,870
| – | – | ﹤0.01% | 146 |
|
|
2022
Q2 | $93K | Hold |
20,870
| – | – | 0.01% | 140 |
|
|
2022
Q1 | $111K | Hold |
20,870
| – | – | 0.01% | 146 |
|
|
2021
Q4 | $307K | Buy |
+20,870
| New | +$307K | 0.01% | 135 |
|